Back
Veeva Systems 10K Form
Sell
50
VEEV
Veeva Systems
Last Price:
$284.35
Seasonality Move:
3.46%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-12-07 | 10Q | VEEV/Veeva Systems Quarterly |
2023-09-01 | 10Q | VEEV/Veeva Systems Quarterly |
2023-06-02 | 10Q | VEEV/Veeva Systems Quarterly |
2022-12-07 | 10Q | VEEV/Veeva Systems Quarterly |
2022-09-02 | 10Q | VEEV/Veeva Systems Quarterly |
2022-06-03 | 10Q | VEEV/Veeva Systems Quarterly |
Receive VEEV News And Ratings
See the #1 stock for the next 7 days that we like better than VEEV
VEEV Financial Statistics
Sales & Book Value
Annual Sales: | $2.7B |
---|---|
Cash Flow: | $877.2M |
Price / Cash Flow: | 38.6 |
Annual Sales: | $38.11 |
Price / Book: | 7.38 |
Profitability
EPS (TTM): | 4.72000 |
---|---|
Net Income (TTM): | $780.7M |
Gross Margin: | $2B |
Return on Equity: | 14.13% |
Return on Assets: | 11.46% |
Veeva Systems Earnings Forecast
Key Veeva Systems Financial Ratios
-
The Gross Profit Margin over the past 15 years for VEEV is 74.53%.
-
The Selling, General & Administrative Expenses for VEEV have been equal to 24.12% of Gross Profit Margin.
-
The Research & Development expenses have been 25.23% of Revenue.
-
The Interest Expense is 0.00% of Operating Income.
-
The Net Earning history of VEEV is 26.00% of Total Revenues.
-
Per Share Earnings over the last 15 years have been positive in 14 years.
Veeva Systems Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Health Care Technology |
Sector: | Health Care |
Current Symbol: | VEEV |
CUSIP: | 922475 |
Website: | veeva.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 4.6 |
Quick Ratio: | 4.54 |
Price-to-Earnings
Trailing P/E Ratio: | 64.96 |
---|---|
Forward P/E Ratio: | 33.72 |
VEEV Technical Analysis vs Fundamental Analysis
Sell
50
Veeva Systems (VEEV)
is a Sell
Is Veeva Systems a Buy or a Sell?
-
Veeva Systems stock is rated a SellThe current Veeva Systems [VEEV] share price is $280.63. The Score for VEEV is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.